Cellular correlates of enhanced anxiety caused by acute treatment with the selective serotonin reuptake inhibitor fluoxetine in rats

Cellular correlates of enhanced anxiety caused by acute treatment with the selective serotonin reuptake inhibitor fluoxetine in rats

Selective serotonin reuptake inhibitors (SSRIs) are used extensively in the treatment of depression and anxiety disorders. The therapeutic benefits of SSRIs typically require several weeks of continuous treatment. Intriguingly, according to clinical reports, symptoms of anxiety may actually increase...

Full description

Bibliographic Details
Main Authors:	Shilpa eRavinder, Anup Gopalakrishna Pillai, Sumantra eChattarji
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2011-12-01
Series:	Frontiers in Behavioral Neuroscience
Subjects:	Amygdala Anxiety Dendritic Spines Fluoxetine Neuronal excitability SSRI
Online Access:	http://journal.frontiersin.org/Journal/10.3389/fnbeh.2011.00088/full

Similar Items

Relation between Fluoxetine and Menstrual Cycle Disorders
by: Zhila Amirkhani, et al.
Published: (2012-09-01)

The Role of Selective Serotonin Reuptake Inhibitors in Premature Ejaculation
by: Alka Aggarwal, et al.
Published: (2017-08-01)

Chronic fluoxetine treatment of juvenile zebrafish (Danio rerio) does not elicit changes in basal cortisol levels and anxiety-like behavior in adulthood
by: Maureen L. Petrunich-Rutherford
Published: (2019-03-01)

Serotonin Transporter Activity in Mouse Oocytes Is a Positive Indicator of Follicular Growth and Oocyte Maturity
by: Nina M. Alyoshina, et al.
Published: (2023-07-01)

Sentiment Analysis of Online Reviews for Selective Serotonin Reuptake Inhibitors and Serotonin–Norepinephrine Reuptake Inhibitors
by: Chad Compagner, et al.
Published: (2021-01-01)

Selective serotonin reuptake inhibitors and violent crime: do SSRI’s kill or cure?
by: S. Sneep, et al.
Published: (2022-06-01)

Potential Role of the Antidepressants Fluoxetine and Fluvoxamine in the Treatment of COVID-19
by: Mohamed Mahdi, et al.
Published: (2022-03-01)

Riluzole prevents stress-induced spine plasticity in the hippocampus but mimics it in the amygdala
by: Saptarnab Naskar, et al.
Published: (2022-05-01)

Does the selective serotonin reuptake inhibitor (SSRI) fluoxetine modify canine anxiety related behaviour?
by: Nicole Echeverri, et al.
Published: (2022-11-01)

Prenatal selective serotonin reuptake inhibitor (SSRI) exposure induces working memory and social recognition deficits by disrupting inhibitory synaptic networks in male mice
by: Weonjin Yu, et al.
Published: (2019-04-01)

Update on the EFFECTS study of fluoxetine for stroke recovery: a randomised controlled trial in Sweden
by: Erik Lundström, et al.
Published: (2020-02-01)

Selective serotonin reuptake inhibitors related bleeding risk: case report and review of literature
by: Andrea Boccatonda, et al.
Published: (2023-08-01)

Secondary and side effects of particular Selective Serotonin Reuptake Inhibitors (SSRIs) antidepressants - literature review
by: Ewa Krzewicka-Romaniuk, et al.
Published: (2020-09-01)

Selective Serotonin Reuptake Inhibitor-Induced Sexual Dysfunction: Current Management Perspectives
by: Atmaca M
Published: (2020-04-01)

Post-Selective Serotonin Reuptake Inhibitor Sexual Dysfunctions (PSSD): Clinical Experience with a Multimodal Approach
by: Yacov Reisman, et al.
Published: (2022-08-01)

Prenatal SSRI Exposure Increases the Risk of Autism in Rodents via Aggravated Oxidative Stress and Neurochemical Changes in the Brain
by: Ramesa Shafi Bhat, et al.
Published: (2023-02-01)

The effects of maternal depression and maternal selective serotonin reuptake inhibitor exposure on the offspring
by: Jocelien DA Olivier, et al.
Published: (2013-05-01)

Effects of the Selective Serotonin Reuptake Inhibitor Fluoxetine on Developing Neural Circuits in a Model of the Human Fetal Cortex
by: Kinsley Tate, et al.
Published: (2021-09-01)

Serotonin Syndrome in an Adolescent as a Result of Suicide with Fluoxetine
by: Raif Yıldız, et al.
Published: (2022-03-01)

Selective serotonin reuptake inhibitor (SSRI) antidepressant treatment discontinuation syndrome: A review of the clinical evidence and the possible mechanisms involved
by: Thibault eRenoir
Published: (2013-04-01)

Investigating Methodological Differences in the Assessment of Dendritic Morphology of Basolateral Amygdala Principal Neurons—A Comparison of Golgi–Cox and Neurobiotin Electroporation Techniques
by: Paul M. Klenowski, et al.
Published: (2017-12-01)

Infant and childhood neurodevelopmental outcomes following prenatal exposure to selective serotonin reuptake inhibitors: overview and design of a Finnish Register-Based Study (FinESSI)
by: Malm Heli, et al.
Published: (2012-12-01)

Neuroplastic effects of a selective serotonin reuptake inhibitor in relearning and retrieval
by: M.B. Reed, et al.
Published: (2021-08-01)

Genetic Background Underlying 5-HT<sub>1A</sub> Receptor Functioning Affects the Response to Fluoxetine
by: Elena M. Kondaurova, et al.
Published: (2020-11-01)

Prenatal Selective Serotonin Reuptake Inhibitor Exposure, Depression, and Brain Morphology in Middle Childhood: Results From the ABCD Study
by: Allison L. Moreau, et al.
Published: (2023-04-01)

Selective serotonin reuptake inhibitors and spermatogenesis
by: M. N. Korshunov, et al.
Published: (2021-07-01)

A systematic review and meta-analysis on the efficacy outcomes of selective serotonin reuptake inhibitors in depression in Alzheimer’s disease
by: Jinli Zhang, et al.
Published: (2023-05-01)

A comparative study of personality aspects of females with depression using the antidepressant medications: selective serotonin reuptake inhibitors (SSRIs) and tricyclic antidepressants (TCAs)
by: Saeed Pournaghash tehrani, et al.
Published: (2018-03-01)

Characteristics of patients with anxiety disorder without selective serotonin reuptake inhibitor prescription over a two‐year period of pharmacotherapy
by: Keisuke Mori, et al.
Published: (2024-03-01)

Fluoxetine pharmacokinetics and tissue distribution quantitatively supports a therapeutic role in COVID-19 at a minimum dose of 20 mg per day [version 3; peer review: 2 approved]
by: Andy R. Eugene
Published: (2022-10-01)

Antidepressant exposure causes a nonmonotonic reduction in anxiety-related behaviour in female mosquitofish
by: Jake M. Martin, et al.
Published: (2020-11-01)

Resolution of Ecchymotic Lesions due to Fluoxetine and Escitalopram after Introduction of Reboxetine
by: Sibel Kocbiyik, et al.
Published: (2015-03-01)

Effects of acute administration of selective serotonin reuptake inhibitors on sympathetic nerve activity
by: R.V. Tiradentes, et al.
Published: (2014-07-01)

Effects of Celecoxib Adjunct to Selective Serotonin Reuptake Inhibitors on Obsessive-Compulsive Disorder
by: Najmeh Shahini, et al.
Published: (2021-07-01)

A Randomized, Double-blind, Placebo - controlled Study of Safety of the Adjunctive Saffron on Sexual Dysfunction Induced by a Selective Serotonin Reuptake Inhibitor
by: P Mansoori, et al.
Published: (2011-03-01)

Testing of analgesic effect of fluoxetine
by: Amra Begović, et al.
Published: (2004-11-01)

Fluoxetine effects on periodontogenesis: histomorphometrical and immunohistochemical analyses in rats
by: Luciana Silva REGUEIRA, et al.

In utero, lactational, or peripartal fluoxetine administration has differential implications on the murine maternal skeleton
by: Hannah P. Fricke, et al.
Published: (2023-10-01)

Comparison of the groups treated with mirtazapine and selective serotonine reuptake inhibitors with respect to birth outcomes and severity of psychiatric disorder
by: Buket Belkız Güngör, et al.
Published: (2019-10-01)

Early life stress-induced alterations in the activity and morphology of ventral tegmental area neurons in female rats
by: Jadwiga Spyrka, et al.
Published: (2020-11-01)